BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 16489538)

  • 1. Association between antibiotic use prior to breast cancer diagnosis and breast tumour characteristics (United States).
    Velicer CM; Heckbert SR; Rutter C; Lampe JW; Malone K
    Cancer Causes Control; 2006 Apr; 17(3):307-13. PubMed ID: 16489538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
    Mariotto AB; Feuer EJ; Harlan LC; Abrams J
    J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgeon characteristics and receipt of adjuvant radiotherapy in women with breast cancer.
    Hershman DL; Buono D; McBride RB; Tsai WY; Joseph KA; Grann VR; Jacobson JS
    J Natl Cancer Inst; 2008 Feb; 100(3):199-206. PubMed ID: 18230795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women.
    Jemal A; Ward E; Thun MJ
    Breast Cancer Res; 2007; 9(3):R28. PubMed ID: 17477859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-related lobular involution and risk of breast cancer.
    Milanese TR; Hartmann LC; Sellers TA; Frost MH; Vierkant RA; Maloney SD; Pankratz VS; Degnim AC; Vachon CM; Reynolds CA; Thompson RA; Melton LJ; Goode EL; Visscher DW
    J Natl Cancer Inst; 2006 Nov; 98(22):1600-7. PubMed ID: 17105983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient and tumor characteristics associated with primary tumor resection in women with Stage IV breast cancer: analysis of 1988-2003 SEER data.
    Gnerlich J; Dueker JM; Jeffe DB; Deshpande AD; Thompson S; Margenthaler JA
    Breast J; 2008; 14(6):538-42. PubMed ID: 19000055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of breast cancer associated with short-term use of oral contraceptives.
    Folger SG; Marchbanks PA; McDonald JA; Bernstein L; Ursin G; Berlin JA; Daling JR; Norman SA; Strom BL; Weiss LK; Simon MS; Burkman RT; Malone KE; Spirtas R
    Cancer Causes Control; 2007 Mar; 18(2):189-98. PubMed ID: 17216547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnancy after treatment of breast cancer--a population-based study on behalf of Danish Breast Cancer Cooperative Group.
    Kroman N; Jensen MB; Wohlfahrt J; Ejlertsen B;
    Acta Oncol; 2008; 47(4):545-9. PubMed ID: 18465320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managed care enrollment and chronically disabled women with breast cancer.
    Habermann EB; Virnig BA; Durham SB; Baxter NN
    Am J Manag Care; 2008 Aug; 14(8):514-20. PubMed ID: 18690767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic use in relation to the risk of breast cancer.
    Velicer CM; Heckbert SR; Lampe JW; Potter JD; Robertson CA; Taplin SH
    JAMA; 2004 Feb; 291(7):827-35. PubMed ID: 14970061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammography surveillance and mortality in older breast cancer survivors.
    Lash TL; Fox MP; Buist DS; Wei F; Field TS; Frost FJ; Geiger AM; Quinn VP; Yood MU; Silliman RA
    J Clin Oncol; 2007 Jul; 25(21):3001-6. PubMed ID: 17548838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of a change in Medicare reimbursement policy and HEDIS measures on stage at diagnosis among Medicare HMO and fee-for-service female breast cancer patients.
    Habermann EB; Virnig BA; Riley GF; Baxter NN
    Med Care; 2007 Aug; 45(8):761-6. PubMed ID: 17667310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is mode of breast cancer detection associated with cancer treatment in the United States?
    Yabroff KR; Harlan LC; Clegg LX; Ballard-Barbash R; Stevens J; Weaver DL
    Cancer; 2008 Mar; 112(5):1011-9. PubMed ID: 18189297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of dementia diagnosis in surveillance, epidemiology, and end results breast cancer survivors who use chemotherapy.
    Heck JE; Albert SM; Franco R; Gorin SS
    J Am Geriatr Soc; 2008 Sep; 56(9):1687-92. PubMed ID: 18691280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of breast cancer in relation to antibiotic use.
    Tamim HM; Hanley JA; Hajeer AH; Boivin JF; Collet JP
    Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):144-50. PubMed ID: 17943999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased breast cancer rates among women with choriocarcinoma.
    Gudipudi DK; Hartzfeld K; Montemarano N; Del Priore G
    Gynecol Oncol; 2008 Aug; 110(2):202-5. PubMed ID: 18514799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance testing among survivors of early-stage breast cancer.
    Keating NL; Landrum MB; Guadagnoli E; Winer EP; Ayanian JZ
    J Clin Oncol; 2007 Mar; 25(9):1074-81. PubMed ID: 17369571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival after bilateral breast cancer: results from a population-based study.
    Verkooijen HM; Chatelain V; Fioretta G; Vlastos G; Rapiti E; Sappino AP; Bouchardy C; Chappuis PO
    Breast Cancer Res Treat; 2007 Nov; 105(3):347-57. PubMed ID: 17186359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supraclavicular radiation for breast cancer does not increase the 10-year risk of stroke.
    Woodward WA; Giordano SH; Duan Z; Hortobagyi GN; Buchholz TA
    Cancer; 2006 Jun; 106(12):2556-62. PubMed ID: 16691617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.